IL135727A0 - Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom - Google Patents

Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom

Info

Publication number
IL135727A0
IL135727A0 IL13572798A IL13572798A IL135727A0 IL 135727 A0 IL135727 A0 IL 135727A0 IL 13572798 A IL13572798 A IL 13572798A IL 13572798 A IL13572798 A IL 13572798A IL 135727 A0 IL135727 A0 IL 135727A0
Authority
IL
Israel
Prior art keywords
nitrogen atom
heterocyclic ring
membered heterocyclic
ring containing
imidazoylalkyl
Prior art date
Application number
IL13572798A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL135727A0 publication Critical patent/IL135727A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13572798A 1997-11-07 1998-11-05 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom IL135727A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96575497A 1997-11-07 1997-11-07
PCT/US1998/023224 WO1999024421A1 (fr) 1997-11-07 1998-11-05 Imidazoylalkyle substitue par un noyau heterocyclique a cinq, six ou sept chainons contenant un atome d'azote

Publications (1)

Publication Number Publication Date
IL135727A0 true IL135727A0 (en) 2001-05-20

Family

ID=25510440

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13572798A IL135727A0 (en) 1997-11-07 1998-11-05 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom

Country Status (12)

Country Link
EP (1) EP1028956A1 (fr)
JP (1) JP2001522845A (fr)
KR (1) KR20010031839A (fr)
CN (1) CN1285828A (fr)
AR (1) AR016671A1 (fr)
AU (1) AU1296799A (fr)
CA (1) CA2309609A1 (fr)
HU (1) HUP0102662A3 (fr)
IL (1) IL135727A0 (fr)
PE (1) PE130699A1 (fr)
WO (1) WO1999024421A1 (fr)
ZA (1) ZA9810186B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140337A (en) * 1997-12-23 2000-10-31 Schering Corporation Methods for the treatment of mental disorders
FR2827863A1 (fr) * 2001-07-27 2003-01-31 Sanofi Synthelabo Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
US7820673B2 (en) 2003-12-17 2010-10-26 Takeda Pharmaceutical Company Limited Urea derivative, process for producing the same, and use
EP2937341B1 (fr) 2004-12-30 2017-07-05 Janssen Pharmaceutica N.V. Dérivés d'phénylamides de 4-(benzyl)-pipérazine-1-acide carboxylique et composés similaires en tant que modulateurs de l'hydrolase des amides d'acides gras (faah) pour le traitement de l'anxiété, de la douleur et d'autres états
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
WO2013151982A1 (fr) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés
WO2022175384A1 (fr) * 2021-02-17 2022-08-25 Fundación Universidad Católica De Valencia San Vicente Mártir Agents à petites molécules ayant une activité antivirale contre des virus à arn

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0619818T3 (da) * 1991-12-18 1996-11-25 Schering Corp Imidazoylalkyl substitueret med en seks-leddet nitrogenholdig heterocyclisk ring
WO1993012108A1 (fr) * 1991-12-18 1993-06-24 Schering Corporation Imidazolyle ou imidazoylalkyle substitue par un azote a quatre ou cinq membres contenant un compose heterocyclique
AU7823894A (en) * 1993-08-27 1995-03-21 Vrije Universiteit New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor
TWI221768B (en) * 1996-08-16 2004-10-11 Schering Corp Pharmaceutical composition comprising histamine H1 receptor antagonist and histamine H3 receptor antagonist providing nasal decongestant effect

Also Published As

Publication number Publication date
HUP0102662A2 (hu) 2001-12-28
PE130699A1 (es) 1999-12-16
KR20010031839A (ko) 2001-04-16
AR016671A1 (es) 2001-07-25
ZA9810186B (en) 1999-05-06
JP2001522845A (ja) 2001-11-20
CN1285828A (zh) 2001-02-28
CA2309609A1 (fr) 1999-05-20
EP1028956A1 (fr) 2000-08-23
WO1999024421A8 (fr) 1999-08-26
HUP0102662A3 (en) 2003-01-28
WO1999024421A1 (fr) 1999-05-20
AU1296799A (en) 1999-05-31

Similar Documents

Publication Publication Date Title
EP0616913A3 (en) High-temperature battery.
HK1032005A1 (en) Polymeric derivatives of camptothecins.
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
HUT68843A (en) Urea derivatives
GB9313020D0 (en) Jitter monitoring
EP0628291A3 (fr) Brosse à dents.
GB9309716D0 (en) Heterocyclic derivatives
ZA941137B (en) Substitutet azolone derivatives.
IL127399A0 (en) 1,3,8-Triaza-spiro (4,5) decan-4-on derivatives
HU9401766D0 (en) Urea derivatives containing heterocyclic ring
IL109451A0 (en) Heterocyclic derivatives
IL135727A0 (en) Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
EP0710107A4 (fr) Derives de n,n,n-trimethylsphingosine
AU7596894A (en) Toothbrush, particularly for one time use
EP0605988A3 (fr) Un élément de support.
GB9311562D0 (en) Heterocyclic derivatives
HU9403010D0 (en) Cyclic amine derivatives
GB9313201D0 (en) New heterocyclic compounds
EP0783488A4 (fr) Composes heterocycliques a cinq elements
ZA936048B (en) Novel 3-oxadiazolyl-1,6-napthyridine derivatives
ZA945728B (en) 7-amino-1,1-dioxocefem l-valylamides
HUT71607A (en) N,n-substituted amino-methylen-imidazolinone derivatives
ZA941763B (en) Carpaine derivatives.
FI96714B (fi) Porauslaitteisto